Xaio-Lian Zhang | Immunology | Best Researcher Award

Published on by Global Academic Awards

Prof. Xaio-Lian Zhang | Immunology | Best Researcher Award

Prof. Xaio-Lian Zhang at Wuhan University, China

Dr. Xiao-Lian Zhang 🎓 is the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. A leading expert in infection, glyco-immunity, and vaccine development 💉, she focuses on immune evasion by Mycobacterium tuberculosis and Hepatitis C/B viruses 🦠. With a PhD from HKUST and postdoc at the University of Maryland , she has published 190+ papers in top journals 📚 and holds 46 patents 🧪. A recipient of China’s Outstanding Young Scientist Fund 🌟, her innovative research in intracellular pathogens and glycan-targeted therapies has been globally recognized and ranked in the top 2% by Faculty of 1000 🌍.

Publication Profile📚

Orcid

Academic Background🎓

Dr. Xiao-Lian Zhang 🎓 earned her PhD in Biochemistry from the Hong Kong University of Science and Technology (1993–1997) and completed her postdoctoral training at the University of Maryland, USA  (1997–2001). She is currently the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. Her research focuses on infection, glyco-immunity, and vaccine development 💉, especially against Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. With over 190 publications 📚, 46 patents 🧪, and numerous national awards 🌟, her work ranks in the top 2% globally 🌍 for its impact and innovation.

Professional background💼

Dr. Xiao-Lian Zhang 💼 is a Hongyi and Luojia Distinguished Professor at Wuhan University and serves as the Chair of the Immunology Department 🧬. She also leads the Hubei Provincial Key Laboratory of Allergic and Immune-related Diseases 🔬. Her research expertise includes infection, glyco-immunity, immune evasion, and vaccine development 💉, particularly targeting Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. She has led major national programs such as the 973 Program and received the National Outstanding Young Scientist Fund 🌟. With over 190 top-tier publications 📚 and 46 granted patents 🧪, she is recognized globally 🌍 for scientific excellence.

Awards and Honors🏅

Dr. Xiao-Lian Zhang 🏅 has received numerous prestigious awards for her outstanding contributions to biomedical research 🌟. She is a recipient of the National Outstanding Young Scientist Fund 🧬 and was selected for China’s “New Century” National Talent Program . As a Hongyi and Luojia Distinguished Professor, she also leads national-level research projects including the 973 Program and Major Infectious Disease Initiatives 🧪. Her innovative work in infection and glyco-immunity has earned over 190 publications 📚 and global recognition, ranking her among the top 2% of scientists worldwide 🌍 according to Faculty of 1000 🏆.

Research Focus🔬

Dr. Xiao-Lian Zhang 🔬 is a leading researcher in infection and immunity, with a special focus on intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. Her groundbreaking work explores glyco-immunity, immune evasion mechanisms, and the development of glycan-targeted vaccines, drugs, and diagnostics 💉🧪. She has pioneered novel approaches in immunotherapy and molecular diagnostics, enhancing both understanding and treatment of infectious diseases 🧬. Her research has been published in prestigious journals 📚 and frequently cited in leading reviews, earning her recognition among the top 2% of global scientists 🌍 for impactful, innovative scientific contributions.

Publication Top Notes🌟

🔬 Mycobacterial EST12 activates a RACK1-NLRP3-gasdermin D pyroptosis-IL-1β immune pathway
Year: 2020 | Published in: Science Advances

🧬 Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication
Year: 2019 | Published in: Nucleic Acids Research

🧪 Detection of circulating Mycobacterium tuberculosis specific DNA by droplet digital PCR for vaccine evaluation
Year: 2018 | Published in: Emerging Microbes & Infections

💉 A Single ssDNA Aptamer Binding to Mannose-Capped Lipoarabinomannan Enhances Immunoprotection against TB
Year: 2016 | Published in: JACS

🧫 Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4⁺ T Cells and Macrophages
Year: 2015 | Published in: Journal of Immunology

🧬 Aptamer against mannose-capped lipoarabinomannan inhibits Mycobacterium tuberculosis in mice and monkeys
Year: 2014 | Published in: Molecular Therapy

🧪 CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents
Year: 2014 | Published in: Journal of Infection

🧬 Ficolin-2 inhibits HCV infection, Apolipoprotein E3 mediates viral immune escape
Year: 2014 | Published in: Journal of Immunology

Conclusion

Professor Xiao-Lian Zhang is a globally recognized leader in infection biology, immunology, and vaccine research 🧬🦠. With a PhD from HKUST and postdoctoral training at the University of Maryland , she currently holds prestigious positions as Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 💼. Her research on glyco-immunity, intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses, and glycan-targeted therapies has led to 190+ high-impact publications 📚 and 46 granted patents 🧪. Widely cited and ranked in the top 2% globally 🌍, she has secured major national grants and made transformative contributions to science, making her a highly deserving candidate for the Best Researcher Award 🏆.

Saeid Amiri Zadeh Fard | Immunology and Microbiology | Best Extension Activity Award

Published on by Global Academic Awards

Dr. Saeid Amiri Zadeh Fard | Immunology and Microbiology | Best Extension Activity Award

Dr. Saeid Amiri Zadeh Fard , Shiraz University of Medical Sciences , Iran

Dr. Saeid Amiri Zadeh Fard is a renowned researcher specializing in virology and biomedical engineering. He currently serves as the Principal Investigator at the Gastroenterohepathology Research Center in Iran. With a strong focus on RNA-based therapeutic strategies, his doctoral research centered around developing short hairpin RNA (shRNA) approaches for targeting Human Respiratory Syncytial Virus (HRSV). Dr. Zadeh Fard has vast expertise in viral analysis, including virus isolation, gene cloning, and RNA transfection, which he applies to novel treatments for viral and immunological diseases. He thrives in collaborative research environments, maintaining an impeccable attention to detail and exceptional organizational skills. Dr. Zadeh Fard has contributed significantly to the field through various teaching and reviewing roles and has an extensive publication record in viral genomics, molecular diagnostics, and therapeutic interventions.

Publication Profile

Orcid

Education 🎓

Dr. Saeid Amiri Zadeh Fard earned his Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). Prior to this, he completed an M.Sc. in Bacteriology at Shahre-Kord University of Medical Sciences (2016-2018), and a B.Sc. from Shiraz Azad University (2011-2016). He also holds an Associate Degree in Medical Sciences from Bandar Abbas University of Medical Sciences (1995-1998). His strong academic background has laid the foundation for his impressive research career in the fields of viral infections, immune regulation, and therapeutic strategies. With specialized training in RNA-based techniques, Dr. Zadeh Fard has made valuable contributions to the understanding and treatment of respiratory and immune-related diseases. His academic journey has been complemented by his continuous involvement in various educational activities, such as teaching microbiology and medical biotechnology courses.

Experience 🏛️

Dr. Saeid Amiri Zadeh Fard’s career spans over two decades in the biomedical and virology research sectors. Since 2018, he has held the position of Principal Investigator at the Gastroenterohepathology Research Center in Iran, where he has advanced research in viral diseases and immunology. His role involves implementing innovative techniques like viral culture, gene cloning, and RNA transfection. Since 2013, Dr. Zadeh Fard has also been the Research Coordinator at the same center, overseeing multiple research projects, training staff, and ensuring high-quality research outcomes. With extensive experience as a Senior Researcher since 2008, he has applied his knowledge in DNA/RNA extraction, cDNA synthesis, and electrophoresis. His teaching experience dates back to 2005, having mentored students in various laboratory techniques and courses in Medical Biotechnology, Medical Engineering, and Medical Laboratory Science. Dr. Zadeh Fard’s extensive expertise has helped shape both research and educational practices in the biomedical field.

Awards and Honors 🏆

Dr. Saeid Amiri Zadeh Fard has earned recognition for his outstanding contributions to medical virology and biotechnology research. Notably, his research on the therapeutic potential of RNA-based interventions in viral diseases has garnered attention internationally. His innovative work in the application of short hairpin RNA (shRNA) for Human Respiratory Syncytial Virus (HRSV) treatment has been highlighted in prestigious scientific publications. Additionally, his role as a reviewer for the Clinica Chimica Acta journal demonstrates his esteemed position within the research community. He has been awarded multiple research grants and continues to be an influential figure in his field, advancing novel therapeutic solutions. His recognition extends to his work as a mentor, having received positive feedback from students and colleagues alike for his contributions to training the next generation of scientists. Dr. Zadeh Fard has also been acknowledged for his dedication to improving laboratory techniques and research protocols.

Research Focus 🔬

Dr. Saeid Amiri Zadeh Fard’s research primarily focuses on viral infections, immune regulation, and the development of novel therapeutic strategies. His doctoral research concentrated on utilizing short hairpin RNA (shRNA) to target Human Respiratory Syncytial Virus (HRSV) replication, presenting a potential new avenue for antiviral therapies. His work includes a detailed understanding of RNA-based molecular techniques, virus isolation, gene cloning, and cell culture systems for the investigation of viral pathogens. Dr. Zadeh Fard’s research extends to studying immune dysregulation in co-infections, particularly HIV and COVID-19, and evaluating therapeutic interventions for immunological disorders. His ongoing research aims to develop advanced strategies for treating viral diseases, such as RSV, and understanding their impact on immune system function. His expertise in virology and biotechnology continues to drive his exploration of molecular diagnostics, antiviral therapies, and immunological disease mechanisms.

Publication Top Notes

Immune Dysregulation in HIV and COVID‐19 Co‐infection: Therapeutic Implications

Comparison of Characteristics and Outcomes of Hepatitis B and Hepatitis C Patients in the Fars Hepatitis Registry

Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment​

Association of Polymorphism of IL‐17A, IL‐17F, and IL‐6 with Toxoplasma gondii Infection Susceptibility in HIV/AIDS Patients in Shiraz, Southern Iran

Simultaneous Detection and Differentiation of Mycobacterium tuberculosis and Nontuberculous Mycobacteria Coexisting in Patients with Pulmonary Tuberculosis by Single-Tube Multiplex PCR​

Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs​

Short Hairpin RNA-Mediated Matrix Gene Silencing of Human Respiratory Syncytial Virus as a Potent Antiviral Strategy

Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection​

Sustained Suppression of Fusion Gene-Mediated Human Respiratory Syncytial Virus Load by shRNA-Based Therapeutics​

Predictors of Death in the Liver Transplantation Adult Candidates: An Artificial Neural Networks and Support Vector Machine Hybrid-Based Cohort Study

Conclusion

Dr. Saeid Amiri Zadeh Fard’s passion for both research and educational outreach, along with his efforts to engage and empower the next generation of scientists, exemplifies the essence of the “Best Extension Activity Award.” His extensive teaching experience, combined with his active involvement in research, aligns perfectly with the goals of extending knowledge and fostering collaborative research. His dedication to advancing science through both applied research and education solidifies his position as a deserving candidate for this prestigious award.

Xiang Yu | Regional Immunity | Best Researcher Award

Published on by Global Academic Awards

Prof. Xiang Yu | Regional Immunity | Best Researcher Award

Prof. Xiang Yu, Hainan University, China

Prof. Xiang Yu is a distinguished immunologist and professor at Hainan University’s School of Biomedical Engineering. He specializes in regional immunity, with a focus on liver immunity and immune visualization. Holding a PhD from Huazhong University of Science and Technology, he has significantly contributed to tumor immunology and nanomedicine. Prof. Yu has published over 59 SCI-indexed papers, including highly cited works in Nature Communications and ACS Nano. His research innovations, including nanovaccines and biomimetic probes, have garnered international recognition. He has supervised numerous doctoral students and received multiple awards, including the Young Scholar Award from the Chinese Society of Immunology.

Publication Profile

Scopus

Orcid

Education 🎓📖

Prof. Xiang Yu obtained a Bachelor’s degree in Clinical Medicine from Wuhan University of Science and Technology in 2013. He later pursued a PhD in Biomedical Engineering at Huazhong University of Science and Technology, graduating in 2019. His doctoral research focused on immune microenvironment regulation, leading to groundbreaking findings in immune visualization and nanomedicine. During his academic journey, he developed expertise in tumor immunology, bio-nanotechnology, and immunotherapeutics. His education laid the foundation for his pioneering work in targeted liver immunity and innovative vaccine designs.

Experience 🏫🔬

Since 2019, Prof. Xiang Yu has been a professor of immunology at Hainan University, mentoring graduate students and leading cutting-edge research projects. His expertise in immune-targeted therapies has driven advancements in biomedical imaging and tumor vaccines. Over the years, he has published over 59 high-impact journal articles, collaborated on international research projects, and contributed to multiple patents. He also holds editorial roles in prestigious journals, serves as a reviewer for SCI-indexed publications, and has been an invited speaker at global immunology conferences.

Awards and Honors 🏆🎖

Prof. Yu has received four major awards, including the Young Scholar Award from the Chinese Society of Immunology. His groundbreaking research has been recognized with the Annual Best Paper Award by Journal of Nanobiotechnology. He has also earned two ESI Highly Cited Paper awards, highlighting his significant impact in immunology and nanomedicine. His students have won national and municipal prizes in academic competitions under his mentorship.

Research Focus 🔬🧬

Prof. Xiang Yu’s research revolves around regional immunity, particularly liver immunity and immune visualization. His work includes bee venom-based liver endothelial targeting, whole-tumor-cell nanovaccines, and biomimetic probes for inflammatory diseases. His studies have led to novel immune regulation strategies for cancer metastasis and autoimmune disorders. His interdisciplinary approach combines bioengineering, nanotechnology, and immunology to develop innovative diagnostic and therapeutic solutions.

Publication Top Notes

  • Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis (Nature Communications, 2019)

  • Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response (Nature Communications, 2020)

  • Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles (Light: Science & Applications, 2020)

  • Biomimetic nanoplatform with selectively positioned indocyanine green for accurate sentinel lymph node imaging (Nanoscale, 2023)

  • Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death (Colloids and Surfaces B: Biointerfaces, 2025)

  • Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection (International Immunopharmacology, 2024)

  • Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice (International Journal of Molecular Sciences, 2024)

  • Mitochondrial stress response in drug-induced liver injury (Molecular Biology Reports, 2021)

  • Hematoxylin and eosin staining of intact tissues via delipidation and ultrasound (Scientific Reports, 2018)

 

 

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Published on by Global Academic Awards

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Mrs Rushna Wazahat, Jamia Hamdard, India

Based on the provided details, Mrs. Rushna Wazahat is a strong candidate for the Best Researcher Award. Her academic background, extensive research experience, and significant contributions to the field of medical microbiology, particularly in tuberculosis diagnosis, make her highly suitable for this award.

Publication profile

google scholar

Education

Mrs. Rushna Wazahat has a robust educational foundation, beginning with a B.Sc. in Botany (Hons.) from Ramjas College, University of Delhi, followed by an M.Sc. in Medical Microbiology from HIMSR, Jamia Hamdard. Her thesis work on the efficacy of diagnostic tools for tuberculosis showcases her early commitment to impactful research. Currently, she is pursuing a Ph.D. at Jamia Hamdard, focusing on novel biomarkers for tuberculosis diagnosis, which underlines her dedication to advancing medical science.

Research & Teaching

With experience as a Junior Research Scientist at Valetude Primus Healthcare and a Tutor/Demonstrator at SGT Medical College, Mrs. Wazahat has gained valuable hands-on experience. Her role as a Research Assistant in a DBT project on innate immunity during Mycobacterium tuberculosis infection further highlights her research acumen. Her ongoing Ph.D. research in the Department of Biochemistry at Jamia Hamdard continues to build on her expertise in tuberculosis research.

Publications

Mrs. Wazahat has published several impactful research papers in reputable journals. Her work spans various aspects of tuberculosis research, including diagnostic methods and epigenetic regulations in Mycobacterium tuberculosis infection. These publications, such as her contributions to the Indian Journal of Tuberculosis and Journal of Microbiological Methods, demonstrate her significant contributions to the field and her ability to communicate complex research effectively.

Seminars & Workshops

Her active participation in international conferences, such as the 2023 International Annual Conference on Medicine and Surgery, and various workshops on scientific writing, ethics, and hospital infection control, reflects her commitment to continuous learning and knowledge dissemination. These engagements not only enhance her own expertise but also contribute to the broader scientific community.

Poster Presentations

Mrs. Wazahat has a strong track record in poster presentations, having won several awards, including the Best Poster Award at the 6th International Leh Symposium 2022. Her success in innovation categories and other competitive events highlights her creativity and ability to present research compellingly.

Extra-Curricular Activities

Her involvement in volunteer work and participation in extracurricular activities, such as calligraphy and leaf mosaic contests, demonstrates her well-rounded personality and commitment to community engagement.

Conclusion

In conclusion, Mrs. Rushna Wazahat’s extensive academic background, impactful research, and active participation in scientific discourse make her an exemplary candidate for the Best Researcher Award. Her work has significant implications for tuberculosis diagnosis and treatment, making her a valuable asset to the scientific community.

Publication top notes

Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii

A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria

Epigenetic regulations in Mycobacterium tuberculosis infection

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Strategic Diagnosis-Unraveling Tuberculosis-A comprehensive Approach

96well-formatted CrfA assay for differentiation of Mycobacterium tuberculosis and Non-tuberculous mycobacteria

Structural basis for the role of C-terminus acidic tail of Saccharomyces cerevisiae ubiquitin-conjugating enzyme (Rad6) in E3 ligase (Bre1) mediated recognition of histones

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Hugues Piloquet | Immunology Award | Excellence in Academia Award

Published on by Global Academic Awards

Dr. Hugues Piloquet | Immunology Award | Excellence in Academia Award

Dr. Hugues Piloquet, CHU de Nantes, University of Nantes, France

Dr. Hugues Piloquet is a distinguished pediatric gastroenterologist 🩺 with a career spanning over two decades. Graduating from the University of Nantes in 1989, he pursued specialized training in pediatric gastroenterology, hepatology, and nutrition. Dr. Piloquet has served in various prestigious roles, including as an Assistant at Necker Enfants Malades and later as a Practitioner at CHU de Nantes. His research contributions extend to INRA-France, where he was affiliated with the Physiology of Nutritional Adaptations unit. With expertise in pediatric gastrointestinal health, Dr. Piloquet continues to impact both clinical practice and research in his field.

 

Publication profile

Scopus

Education

Dr. Hugues Piloquet, born on July 18, 1965, embarked on his medical career with a Doctorate in Medicine from the University of Nantes in 1989. Specializing further, he obtained his DES in Pediatrics from the same institution in 1995, followed by a Master’s in Human Biology in 1993. His passion for pediatric gastroenterology led him to pursue advanced studies, including a DEA in Physiology and Pathophysiology of Human Nutrition from Paris VII. With a commitment to excellence, Dr. Piloquet completed a DIU in Pediatric Gastroenterology, Hepatology, and Nutrition in 1998.

Professional Experience 👨‍⚕️

Dr. Piloquet’s professional journey includes pivotal roles at esteemed institutions. He served as an Assistant at the Pediatric Gastroenterology Department under Pr. Claude Ricour at Necker Enfants Malades from 1995 to 1996. Progressing in his career, he assumed the role of Assistant-Chef de Clinique at the General Pediatrics Department under Pr. Alain Mouzard at CHU de Nantes in 1998. His dedication led him to become a Practitioner at CHU de Nantes in 1999, where he served as a hospital physician.

Research Focus

Dr. Hélène Piloquet’s research primarily focuses on pediatric nutrition and gastrointestinal health 🍼. She has contributed significantly to understanding the impact of early life gut microbiota on infant health, as evidenced by her work on synbiotic formulas and partially hydrolyzed whey-based follow-on formulas. Additionally, her studies explore the association between food fussiness in young children and family environmental factors. Through her research, Dr. Piloquet aims to optimize nutritional interventions for infants and toddlers, promoting healthy growth and development. Her interdisciplinary approach underscores the importance of nutrition in pediatric healthcare, addressing both clinical and environmental influences on children’s well-being.

Publication Top Notes

Food fussiness is associated with family environmental factors in 1-3-year-old children: A large-scale cross-sectional study

Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk

Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants

A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life

Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents

Frequency of Abnormal Glucose Tolerance Test Suggestive of Dumping Syndrome Following Oesophageal Atresia Repair

A 1-year survey of catheter-related infections in a pediatric university hospital: A prospective study

 

Maxwell Hubert Antwi | Immunology | Best Researcher Award

Published on by Global Academic Awards

Mr. Maxwell Hubert Antwi | Immunology | Best Researcher Award

Mr. Maxwell Hubert Antwi, Koforidua Technical University, Ghana

Dr. Maxwell Hubert Antwi is a dedicated researcher and educator in the field of Medical Laboratory Science. He holds a PhD and serves as an Assistant Lecturer at Koforidua Technical University, Ghana. His research interests encompass immunology, proteomics, global health, and infectious diseases like malaria. Dr. Antwi has authored several impactful publications, contributing significantly to the scientific community’s understanding of various health issues. Beyond academia, he actively engages in community service and professional development activities. With proficiency in Microsoft Office and Python programming, Dr. Antwi is also known for his leadership qualities and fluency in English and French. 🌍🔬

Publication Profile:

Orcid

Google Scholar

 

Education:

Maxwell Hubert Antwi pursued his academic journey with fervor, obtaining an MSc in Medical Laboratory Science from Kwame Nkrumah University of Science and Technology, Ghana, in 2018. His research delved into the intricate relationship between Vitamin D deficiency and cytokines (IL 10, TNF-alpha, IFN-gamma), under the guidance of esteemed Professor Samuel Asamoah Sakyi. Prior to this, he earned a BSc in Medical Laboratory Science from the University of Ghana in 2012. His undergraduate thesis, supervised by Professor E.K Wiredu, focused on the prevalence of unsatisfactory Pap smear reports and the potential association with cancer cell presence. 🎓

Certificate:

Maxwell Hubert Antwi expanded his expertise through a certificate program in Civil Society Management, a collaborative effort by the Young African Leadership Initiative (YALI-West Africa) and the Ghana Institute of Management and Public Administration (GIMPA). 🌍 Focusing on environmental sustainability, his research under the guidance of the Regional Leadership Center-West Africa (YALI-GIMPA) centered on single-use plastic waste management. This initiative showcased his commitment to addressing pressing global challenges and his dedication to making a positive impact on society. 🌱 Through this program, he honed his leadership skills and gained valuable insights into fostering community-driven solutions for a cleaner, healthier planet.

Awards and Honors:

Maxwell Hubert Antwi’s exceptional achievements have been recognized through prestigious honors and awards. In 2023, he received the Presidential Honour for Distinguished Service Award for his remarkable contributions during the COVID-19 pandemic, bestowed by the President of the Republic of Ghana at the Jubilee House. 🏅 Additionally, his leadership prowess was evident in 2019 when he was part of the winning team, earning the Young African Leadership Initiative (YALI) Pitching Award during Cohort 14 Training at the Regional Leadership Center-West Africa-Accra. 🌟 Antwi’s academic excellence was evident early on, as he was named the Best graduating student at The Comforter Junior High School in Kumasi, Ghana, in 2003. 🎓

 

Teaching Experience :

Maxwell Hubert Antwi has demonstrated a strong commitment to education through his extensive teaching experience in the medical field. 📚 Joining Koforidua Technical University’s Medical Laboratory Science Department in 2021 as an Assistant Lecturer, he imparted knowledge to undergraduate students in various courses, including Haematology, Medical Immunology, and Health and Safety. His dedication continued in previous years, where he engaged students at different levels of their academic journey, fostering learning environments conducive to growth and development. Antwi’s teaching expertise also extended beyond the university setting, as he contributed to the education of nursing students at Navrongo Community Nursing College. 🎓 His hands-on approach and commitment to student success exemplify his passion for teaching and mentorship.

 

Research Focus:

Maxwell Hubert Antwi’s research primarily focuses on public health, with a particular emphasis on infectious diseases and epidemiology. 🦠 His studies encompass a wide range of topics, including the prevalence and determinants of various health conditions such as Vitamin D deficiency, cancer burden attributable to risk factors, and the impact of infectious diseases like malaria and COVID-19. 🩺 Antwi’s work contributes significantly to understanding disease patterns, risk factors, and potential interventions, thereby aiding in the development of strategies for disease prevention and management. 🌍 Through his research endeavors, he strives to make meaningful contributions to global health and well-being.

Publication Top Notes:

  1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …. 🩺 Cited by: 873, Year: 2022
  2. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 🌍 Cited by: 339, Year: 2022
  3. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 🔬 Cited by: 20, Year: 2023
  4. Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers 💉 Cited by: 16, Year: 2021
  5. Prevalence and determinants of low testosterone levels in men with type 2 diabetes mellitus; a case-control study in a district hospital in Ghana 📉 Cited by: 10, Year: 2021
  6. A comparative analysis of the knowledge and stigmatizing attitude of Ghanaians and Nigerians towards COVID-19 survivors 🤝 Cited by: 7, Year: 2021
  7. Vitamin D deficiency is common in Ghana despite abundance of sunlight: A multicentre comparative cross-sectional study ☀️ Cited by: 6, Year: 2021
  8. Prevalence of Unsatisfactory Pap Smear and Associated Clinical History and Diagnosis in a Tertiary Teaching Hospital in Ghana 🩺 Cited by: 2, Year: 2019
  9. Assessment of platelet numbers and prevalence of thrombocytopenia among children with severe malaria at a tertiary teaching hospital🦟 Cited by: 1, Year: 2021
  10. Chemokine Receptors Expression on Peripheral CD4-Lymphocytes in Rheumatoid Arthritis: CD4+ CD183+ As A Diagnostics Marker for Disease Activity in Rheumatoid Arthritis 🔄 Year: 2024

 

Immunology and Microbiology

Published on by Global Academic Awards

Introduction of Immunology and Microbiology

 

Immunology and Microbiology research stands at the crossroads of health and disease, uncovering the intricacies of the immune system and the remarkable world of microorganisms. This field plays a pivotal role in our understanding of infectious diseases, immune responses, and the development of vaccines and therapies. Researchers in immunology and microbiology explore the complexities of viruses, bacteria, and the immune system to safeguard global health and advance medical science.

Virology:

Virologists investigate viruses, their structure, replication mechanisms, and their interactions with host cells. This subfield is critical for understanding and combating viral diseases such as HIV, influenza, and COVID-19.

Immunotherapy:

Researchers in immunotherapy work on harnessing the power of the immune system to treat diseases, particularly cancer. Their efforts include developing immunotherapeutic agents and personalized treatments.

Bacteriology:

Bacteriologists focus on bacteria, studying their growth, genetics, and their role in infections. This research is vital for combating antibiotic-resistant bacteria and emerging infectious diseases.

Microbiome Research:

Microbiome researchers explore the communities of microorganisms that inhabit the human body and the environment. Their work provides insights into the role of microbiota in health, disease, and environmental sustainability.

Immunological Disorders:

Researchers in this subfield delve into autoimmune diseases, allergies, and immunodeficiencies. They aim to unravel the underlying causes and develop treatments to restore immune system balance.

[post_grid id=”12288″]